phosphorylcholine has been researched along with Bronchopulmonary Dysplasia in 15 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A haemodynamically significant patent ductus arteriosus was clinically evident significantly earlier in babies who had received Survanta (mean age 1." | 1.29 | Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation. ( Malathi, I; Ng, KC, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (93.33) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moya, F | 1 |
| Corbet, A | 4 |
| Gerdes, J | 1 |
| Long, W | 6 |
| Avila, E | 1 |
| Puri, A | 1 |
| Rosenberg, A | 1 |
| Edwards, K | 1 |
| Cook, L | 1 |
| Hudak, ML | 2 |
| Farrell, EE | 1 |
| Rosenberg, AA | 2 |
| Jung, AL | 2 |
| Auten, RL | 2 |
| Durand, DJ | 1 |
| Horgan, MJ | 1 |
| Buckwald, S | 1 |
| Belcastro, MR | 2 |
| Donohue, PK | 2 |
| Carrion, V | 1 |
| Maniscalco, WW | 1 |
| Balsan, MJ | 1 |
| Torres, BA | 1 |
| Miller, RR | 1 |
| Jansen, RD | 2 |
| Graeber, JE | 1 |
| Laskay, KM | 1 |
| Matteson, EJ | 2 |
| Egan, EA | 2 |
| Brody, AS | 2 |
| Martin, DJ | 2 |
| Riddlesberger, MM | 2 |
| Montgomery, P | 2 |
| Malathi, I | 1 |
| Ng, KC | 1 |
| Cummings, NJ | 1 |
| Kimberlin, LV | 1 |
| Asselin, JM | 1 |
| Hamm, CR | 1 |
| Husain, AN | 1 |
| Siddiqui, NH | 1 |
| Stocker, JT | 1 |
| Helbich, TH | 1 |
| Popow, C | 1 |
| Dobner, M | 1 |
| Wunderbaldinger, P | 1 |
| Zekert, M | 1 |
| Herold, CJ | 1 |
| Stevenson, D | 1 |
| Walther, F | 1 |
| Sell, M | 1 |
| Pauly, T | 1 |
| Gong, A | 1 |
| Easa, D | 1 |
| Pramanik, A | 1 |
| LeBlanc, M | 1 |
| Anday, E | 1 |
| Levine, D | 1 |
| Edwards, DK | 1 |
| Merritt, TA | 1 |
| Cotton, R | 1 |
| Courtney, S | 1 |
| McGuiness, G | 1 |
| Walter, D | 1 |
| Watts, J | 1 |
| Smyth, J | 1 |
| Bard, H | 1 |
| Chernick, V | 1 |
| Corbet, AJ | 1 |
| Long, WA | 1 |
| Murphy, DJ | 1 |
| Garcia-Prats, JA | 1 |
| Lombardy, LR | 1 |
| Wold, DE | 1 |
| Bucciarelli, R | 1 |
| Goldman, S | 1 |
| Mammel, M | 1 |
| Wold, D | 2 |
| Thompson, T | 1 |
| Sundell, H | 1 |
| Schumacher, R | 1 |
| Volberg, F | 1 |
| Guthrie, R | 1 |
| Etches, PC | 1 |
| Peliowski, A | 1 |
| Finer, NN | 1 |
| Tierney, AJ | 1 |
| Bose, C | 1 |
| Bose, G | 1 |
| Garcia-Prats, J | 1 |
| Lombardy, L | 1 |
| Donlon, D | 1 |
1 review available for phosphorylcholine and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Synthetic surfactants: where are we? Evidence from randomized, controlled clinical trials.
Topics: Animals; Biological Products; Bronchopulmonary Dysplasia; Dose-Response Relationship, Drug; Drug Com | 2009 |
9 trials available for phosphorylcholine and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa.
Topics: Bronchopulmonary Dysplasia; Cause of Death; Double-Blind Method; Drug Administration Schedule; Drug | 1995 |
A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
Topics: Bronchopulmonary Dysplasia; Cross-Over Studies; Drug Combinations; Fatty Alcohols; Humans; Incidence | 1996 |
A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
Topics: Age Factors; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Data Interpretation, Statistical; Drug | 1997 |
Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.
Topics: Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Double-Blind Method; Drug Combinations; Ductus Arte | 1992 |
A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Topics: Birth Weight; Bronchopulmonary Dysplasia; Child; Drug Combinations; Fatty Alcohols; Female; Follow-U | 1991 |
Reduced mortality in small premature infants treated at birth with a single dose of synthetic surfactant.
Topics: Bronchopulmonary Dysplasia; Drug Combinations; Fatty Alcohols; Follow-Up Studies; Humans; Incidence; | 1991 |
Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1.
Topics: Bronchopulmonary Dysplasia; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Infa | 1991 |
Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
Topics: Bronchopulmonary Dysplasia; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Fa | 1991 |
Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant.
Topics: Bronchopulmonary Dysplasia; Cause of Death; Double-Blind Method; Drug Combinations; Fatty Alcohols; | 1990 |
5 other studies available for phosphorylcholine and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation.
Topics: Biological Products; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Drug Combinations; Ductus Arte | 1995 |
Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia.
Topics: Biological Products; Body Weight; Bronchopulmonary Dysplasia; Drug Combinations; Fatty Alcohols; Fem | 1998 |
New-born infants with severe hyaline membrane disease: radiological evaluation during high frequency oscillatory versus conventional ventilation.
Topics: Bronchopulmonary Dysplasia; Case-Control Studies; Drug Combinations; Fatty Alcohols; Female; High-Fr | 1998 |
Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings.
Topics: Bronchopulmonary Dysplasia; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylch | 1991 |
Effect of institutional differences on study of surfactant in two centers.
Topics: Bronchopulmonary Dysplasia; Drug Combinations; Fatty Alcohols; Hospitals; Humans; Infant, Low Birth | 1991 |